Scientists Find Novel Approach to Treating Number 1 Cause of Blindness in Elderly
Florida Atlantic UniversityScientists at Florida Atlantic University have found that sulindac, a known anti-inflammatory drug, can protect against oxidative damage due to age-related macular degeneration (AMD). Their studies suggest that sulindac could be an inexpensive and relatively non-toxic therapeutic approach for treating AMD, one of the primary causes of vision loss in the elderly. AMD gradually destroys sharp, central vision, which is needed for seeing objects clearly and for common daily tasks such as reading and driving. Currently, no cures exist for the majority of AMD cases.